Annual report pursuant to Section 13 and 15(d)

NOTE 7. REVERSE ACQUISITION (Details Narrative)

v2.4.0.6
NOTE 7. REVERSE ACQUISITION (Details Narrative)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Note 7. Reverse Acquisition Details Narrative    
Acquisition of additional interest 1.08%  
Description of acquisition through exchange of common shares Exchange of 251,105 TransBiotec - DE common shares for 32,500 TransBiotec - CA common shares  
Interest acquired 98.62% 97.54%